{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:08:40Z","timestamp":1781629720738,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vellore Institute of Technology, Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Viral proteases are critical components in the life cycles of many dangerous viruses, playing a direct role in facilitating viral replication. Targeting these enzymes through inhibition offers a promising strategy for advancing antiviral agents. This study explores the potential of pigmented actinomycetes from high-altitude terrestrial environments as sources of antiviral agents against SARS-CoV-2, with a particular focus on identifying protease inhibitors. From this unique ecological niche,\n                    <jats:italic>Streptomyces globosus<\/jats:italic>\n                    VITSMAB2 was isolated and identified as a promising candidate due to its significant protease-inhibiting capabilities. Both qualitative and quantitative assays confirmed its strong inhibitory activity against key proteases, especially cysteine and serine proteases such as papain and trypsin. Protease inhibitory compounds were partially purified using Ultra-Performance Liquid Chromatography (UPLC), and their identities were determined through Gas Chromatography\u2013Mass Spectrometry (GC-MS) analysis. Among the identified compounds, phenyl carbamate was the most prevalent and emerged as the lead molecule as protease inhibitor. Molecular docking studies revealed that phenyl carbamate exhibited strong binding interactions with the main protease (M-pro) of SARS-CoV-2, highlighting its potential as an antiviral agent. Additionally, assessments of the compound\u2019s drug-likeness and ADME\/T (absorption, distribution, metabolism, excretion, and toxicity) profiles indicated favorable pharmacokinetic properties, supporting its candidacy for therapeutic development. Molecular dynamics simulations further confirmed the stability of the phenyl carbamate-M-protease complex, reinforcing the compound\u2019s antiviral potential. Therefore, phenyl carbamate shows considerable promise as a lead antiviral compound and merits further validation through extensive in vitro and in vivo experimentation to fully assess its therapeutic efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-31329-y","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T14:35:46Z","timestamp":1765636546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational insights into a protease inhibitor from Streptomyces globosus VITSMAB-2 molecular docking and dynamics simulations against SARS-CoV-2 main protease"],"prefix":"10.1038","volume":"16","author":[{"given":"Shatakshi","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stany Bala","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparana","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Bhaskara Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"31329_CR1","first-page":"63","volume":"7","author":"BS Chhikara","year":"2020","unstructured":"Chhikara, B. S., Rathi, B. & Singh, J. Poonam. Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chem. Biology Lett. 7, 63\u201372 (2020).","journal-title":"Chem. Biology Lett."},{"key":"31329_CR2","doi-asserted-by":"publisher","first-page":"101159","DOI":"10.1016\/j.mam.2022.101159","volume":"88","author":"T Majerov\u00e1","year":"2022","unstructured":"Majerov\u00e1, T. & Konvalinka, J. Viral proteases as therapeutic targets. Mol. Aspects Med. 88, 101159 (2022).","journal-title":"Mol. Aspects Med."},{"key":"31329_CR3","doi-asserted-by":"crossref","unstructured":"Zephyr, J., Kurt Yilmaz, N. & Schiffer, C. A. Chapter Nine - Viral proteases: Structure, mechanism and Inhibition. in Viral Replication Enzymes and their Inhibitors Part B (eds Cameron, C. E., Arnold, J. J. & Kaguni, L.) (2021). S. B. T.-T. E.) vol. 50 301\u2013333 (Academic, 2021).","DOI":"10.1016\/bs.enz.2021.09.004"},{"key":"31329_CR4","doi-asserted-by":"publisher","first-page":"126858","DOI":"10.1016\/j.micres.2021.126858","volume":"252","author":"N Kamarudheen","year":"2021","unstructured":"Kamarudheen, N., Khaparde, A., Gopal, S. & Rao, K. V. B. Unraveling a natural protease inhibitor from marine streptomyces Griseoincarnatus HK12 active against Chikungunya virus. Microbiol. Res. 252, 126858 (2021).","journal-title":"Microbiol. Res."},{"key":"31329_CR5","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.bbagen.2006.03.002","volume":"1760","author":"L Angelova","year":"2006","unstructured":"Angelova, L. et al. Purification and characterisation of a protease inhibitor from streptomyces chromofuscus 34\u2009\u2013\u20091 with an antiviral activity. Biochim. Et Biophys. Acta (BBA) - Gen. Subj. 1760, 1210\u20131216 (2006).","journal-title":"Biochim. Et Biophys. Acta (BBA) - Gen. Subj."},{"key":"31329_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s42269-021-00606-x","volume":"45","author":"OM Adeyemo","year":"2021","unstructured":"Adeyemo, O. M., Ja\u2019afaru, M. I. & Adams, F. V. Isolation, characterization, antimicrobial and other bioactivity profiles of three streptomyces strains isolated from lake Gerio, Yola, Adamawa State, Nigeria. Bull. Natl. Res. Cent. 45, 147 (2021).","journal-title":"Bull. Natl. Res. Cent."},{"key":"31329_CR7","doi-asserted-by":"publisher","first-page":"127130","DOI":"10.1016\/j.micres.2022.127130","volume":"263","author":"M Rudrappa","year":"2022","unstructured":"Rudrappa, M. et al. Bioproduction, purification and physicochemical characterization of melanin from streptomyces sp. strain MR28. Microbiol. Res. 263, 127130 (2022).","journal-title":"Microbiol. Res."},{"key":"31329_CR8","doi-asserted-by":"publisher","first-page":"103559","DOI":"10.1016\/j.bcab.2025.103559","volume":"65","author":"S Mishra","year":"2025","unstructured":"Mishra, S., Stany, B., Kumari, A. & Bhaskara Rao, K. V. Protease inhibitor from streptomyces pulveraceus strain VITSSAB as a potential therapeutic agent against BACE1 in alzheimer\u2019s disease: A molecular Docking and dynamics simulations study. Biocatal. Agric. Biotechnol. 65, 103559 (2025).","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"31329_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0090972","volume":"9","author":"L Karthik","year":"2014","unstructured":"Karthik, L. et al. Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLoS One. 9, 1\u201313 (2014).","journal-title":"PLoS One"},{"key":"31329_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/oxfordjournals.molbev.a026231","volume":"17","author":"WJ Bruno","year":"2000","unstructured":"Bruno, W. J., Socci, N. D. & Halpern, A. L. Weighted neighbor joining: a likelihood-based approach to distance-based phylogeny reconstruction. Mol. Biol. Evol. 17, 189\u2013197 (2000).","journal-title":"Mol. Biol. Evol."},{"key":"31329_CR11","doi-asserted-by":"publisher","first-page":"103003","DOI":"10.1016\/j.fbio.2023.103003","volume":"55","author":"T Buragohain","year":"2023","unstructured":"Buragohain, T., Dey, P. & Osborne, W. J. In vitro studies on the Inhibition of microbial pathogens by PPDHMP synthesized by Bacillus sp.; an endophyte of citrus Limon (Kaji nemu). Food Biosci. 55, 103003 (2023).","journal-title":"Food Biosci."},{"key":"31329_CR12","doi-asserted-by":"crossref","unstructured":"Tang, S. et al. Accelerating AutoDock Vina with GPUs. Molecules 27, (2022).","DOI":"10.3390\/molecules27093041"},{"key":"31329_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10717-4","author":"G Singh","year":"2023","unstructured":"Singh, G. et al. Repurposing the in-house generated alzheimer\u2019s disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-023-10717-4 (2023).","journal-title":"Mol. Divers."},{"key":"31329_CR14","doi-asserted-by":"publisher","unstructured":"de Queiroz Sim\u00f5es, R. S. et al. Computational Modeling in Virus Infections and Virtual Screening, Docking, and Molecular Dynamics in Drug Design BT - Networks in Systems Biology: Applications for Disease Modeling. In da Silva, F. A. B., Carels, N., Trindade dos Santos, M.J. P. 301\u2013337 (Springer International Publishing, Cham, 2020). https:\/\/doi.org\/10.1007\/978-3-030-51862-2_12","DOI":"10.1007\/978-3-030-51862-2_12"},{"key":"31329_CR15","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"31329_CR16","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G. et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, W5\u2013W14 (2021).","journal-title":"Nucleic Acids Res."},{"key":"31329_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2018.07.046","volume":"549","author":"CM Chagas","year":"2018","unstructured":"Chagas, C. M., Moss, S. & Alisaraie, L. Drug metabolites and their effects on the development of adverse reactions: revisiting lipinski\u2019s rule of five. Int. J. Pharm. 549, 133\u2013149 (2018).","journal-title":"Int. J. Pharm."},{"key":"31329_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12032-024-02406-5","volume":"41","author":"B Stany","year":"2024","unstructured":"Stany, B., Mishra, S. & Rao, K. V. B. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer. Med. Oncol. 41, 156 (2024).","journal-title":"Med. Oncol."},{"key":"31329_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/347631a0","volume":"347","author":"M Karplus","year":"1990","unstructured":"Karplus, M. & Petsko, G. A. Molecular dynamics simulations in biology. Nature 347, 631\u2013639 (1990).","journal-title":"Nature"},{"key":"31329_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina, A. & Zoete, V. A BOILED-Egg to predict Gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11, 1117\u20131121 (2016).","journal-title":"ChemMedChem"},{"key":"31329_CR21","first-page":"1374","volume":"371","author":"J Qiao","year":"2021","unstructured":"Qiao, J. et al. SARS-CoV-2 M pro inhibitors with antiviral activity in a Transgenic mouse model. Sci. (1979). 371, 1374\u20131378 (2021).","journal-title":"Sci. (1979)"},{"key":"31329_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"31329_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40203-025-00336-2","volume":"13","author":"N Kumar","year":"2025","unstructured":"Kumar, N., Gond, C., Singh, J. D. & Datta, A. Molecular docking, Pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and Spike protein. Silico Pharmacol. 13, 44 (2025).","journal-title":"Silico Pharmacol."},{"key":"31329_CR24","doi-asserted-by":"publisher","first-page":"118144","DOI":"10.1016\/j.ejmech.2025.118144","volume":"300","author":"AH Khan","year":"2025","unstructured":"Khan, A. H. et al. Mitigating SARS-CoV-2\u2013exacerbated neuroinflammation and alzheimer\u2019s pathology: synthesis of quinoline-based dual inhibitors targeting cysteine and aspartyl proteases. Eur. J. Med. Chem. 300, 118144 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"31329_CR25","doi-asserted-by":"publisher","first-page":"107463","DOI":"10.1016\/j.compbiolchem.2021.107463","volume":"92","author":"L Soul\u00e8re","year":"2021","unstructured":"Soul\u00e8re, L., Barbier, T. & Queneau, Y. Docking-based virtual screening studies aiming at the covalent Inhibition of SARS-CoV-2 MPro by targeting the cysteine 145. Comput. Biol. Chem. 92, 107463 (2021).","journal-title":"Comput. Biol. Chem."},{"key":"31329_CR26","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3390\/molecules26072082","volume":"26","author":"MAA Ibrahim","year":"2021","unstructured":"Ibrahim, M. A. A. et al. In Silico mining of terpenes from Red-Sea invertebrates for SARS-CoV-2 main protease (Mpro) inhibitors. Molecules 26, 2082 (2021).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31329-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:29:42Z","timestamp":1781627382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31329"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31329-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1778"}}